| 2025-11-24 |
股东大会：
将于2025-12-22召开股东大会
会议内容 ▼▲
- 1.To elect two Class II directors each to hold office until 2028
2.To approve an amendment of the Company’s Amended and Restated Certificate of Incorporation, as amended, to increase the total number of authorized shares of common stock, $0.0001 par value per share (the “Common Stock”), from 125,000,000 shares to 250,000,000 shares.
3.To approve, for purposes of complying with Nasdaq Listing Rules, including Rule 5635(d), the issuance of shares of Common Stock upon the conversion of the Company’s Series A Convertible Voting Preferred Stock, par value $0.0001 per share (“Series A Preferred Stock”), including shares of Common Stock issuable upon the conversion of any Series A Preferred Stock issuable upon exercise of warrants to purchase Series A Preferred Stock.
4.To approve an amendment to the Company’s Amended and Restated 2013 Equity Incentive Plan (the “2013 Plan”) to, among other things, increase the aggregate number of shares of Common Stock authorized for issuance under the 2013 Plan by 12,500,000 shares.
5.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.
6.To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025.
7.To conduct any other business properly brought before the meeting.
|
| 2025-11-24 |
详情>>
股本变动：
变动后总股本699.34万股
|
| 2025-11-17 |
复牌提示：
2025-11-17 10:13:49 停牌，复牌日期 2025-11-17 10:18:49
|
| 2025-11-05 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-1.29美元,归母净利润-975.55万美元,同比去年增长-270.82%
|
| 2025-08-14 |
详情>>
业绩披露：
2025年中报每股收益-0.93美元,归母净利润-701.16万美元,同比去年增长58.27%
|
| 2025-05-13 |
详情>>
业绩披露：
2025年一季报每股收益-0.5美元,归母净利润-375.3万美元,同比去年增长56.20%
|
| 2025-02-25 |
详情>>
业绩披露：
2024年年报每股收益0.19美元,归母净利润143.89万美元,同比去年增长104.80%
|
| 2024-11-05 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.75美元,归母净利润571.09万美元,同比去年增长127.22%
|
| 2024-10-22 |
股东大会：
将于2024-12-05召开股东大会
会议内容 ▼▲
- 1.To elect two Class I directors, Hans Peter Hasler and Dr. Remy Luthringer, to the Board of Directors to hold office until the 2027 Annual Meeting of Stockholders.
2.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.
3.To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024.
4.To conduct any other business properly brought before the meeting.
|
| 2024-08-06 |
详情>>
业绩披露：
2024年中报每股收益-2.22美元,归母净利润-1680.23万美元,同比去年增长-27.65%
|
| 2024-05-01 |
详情>>
业绩披露：
2024年一季报每股收益-1.13美元,归母净利润-856.88万美元,同比去年增长-22.93%
|
| 2024-02-22 |
详情>>
业绩披露：
2023年年报每股收益-4.61美元,归母净利润-3000.54万美元,同比去年增长6.55%
|
| 2023-11-07 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-3.41美元,归母净利润-2098.29万美元,同比去年增长17.33%
|
| 2023-08-15 |
股东大会：
将于2023-09-27召开股东大会
会议内容 ▼▲
- 1.To elect two Class III directors, David Kupfer and Jan van Heek, to the Board of Directors to hold office until the 2026 Annual Meeting of Stockholders.
2.To approve an amendment to the Company’s Amended and Restated 2013 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 700,000 shares.
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.
4.To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2023.
5.To conduct any other business properly brought before the meeting.
|
| 2023-08-01 |
详情>>
业绩披露：
2023年中报每股收益-2.43美元,归母净利润-1316.24万美元,同比去年增长28.78%
|
| 2023-05-15 |
财报披露：
美东时间 2023-05-15 盘前发布财报
|
| 2023-04-28 |
详情>>
内部人交易：
Luthringer Remy等共交易7笔
|
| 2022-06-21 |
详情>>
拆分方案：
每8.0000合并分成1.0000股
|
| 2022-04-26 |
股东大会：
将于2022-06-10召开股东大会
会议内容 ▼▲
- 1.To elect the Board of Directors’ nominees, Jeryl Hilleman, Fouzia Laghrissi-Thode and Remy Luthringer, to the Board of Directors to hold office until the 2025 Annual Meeting of Stockholders.
2.To approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock split of our common stock at a ratio in the range of 1-for-4 and 1-for-10, with such ratio to be determined in the discretion of the Board of Directors.
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.
4.To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2022.
5.To approve the authorization to adjourn the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposal 2.
6.To conduct any other business properly brought before the meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-30 |
股东大会：
将于2021-06-11召开股东大会
会议内容 ▼▲
- 1.To elect the Board of Directors’ nominees, William F. Doyle and Hans Peter Hasler, to the Board of Directors to hold office until the 2024 Annual Meeting of Stockholders.
2.To approve a one-time stock option exchange program, or the Exchange Program, as disclosed in this proxy statement.
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.
4.To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2021.
5.To conduct any other business properly brought before the meeting.
|
| 2020-04-28 |
股东大会：
将于2020-06-19召开股东大会
会议内容 ▼▲
- 1.To elect the Board of Directors’ nominees, David Kupfer and Jan van Heek, to the Board of Directors to hold office until the 2023 Annual Meeting of Stockholders.
2.To approve the Company’s Amended and Restated 2013 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 2,000,000 shares.
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.
4.To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company’s named executive officers.
5.To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2020.
6.To conduct any other business properly brought before the meeting.
|
| 2019-04-17 |
股东大会：
将于2019-05-31召开股东大会
会议内容 ▼▲
- 1.To elect the Board of Directors’ nominees, Dr. Remy Luthringer, Dr. Fouzia Laghrissi-Thode and Jeryl Lynn Hilleman, to the Board of Directors to hold office until the 2022 Annual Meeting of Stockholders.
2.To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2019.
3.To conduct any other business properly brought before the meeting.
|
| 2018-04-24 |
股东大会：
将于2018-06-07召开股东大会
会议内容 ▼▲
- 1.To elect the Board of Directors’ nominees, William F. Doyle and Hans Peter Hasler to the Board of Directors to hold office until the 2021 Annual Meeting of Stockholders.
2.To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2018.
3.To approve the Company’s Amended and Restated 2013 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 2,500,000 shares.
4.To conduct any other business properly brought before the meeting.
|
| 2017-04-18 |
股东大会：
将于2017-06-01召开股东大会
会议内容 ▼▲
- 1.To elect the Board of Directors’ nominees, Marc D. Beer, Dr. David Kupfer, and Jan van Heek to the Board of Directors to hold office until the 2020 Annual Meeting of Stockholders.
2.To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2017.
3.To conduct any other business properly brought before the meeting.
|
| 2016-04-29 |
股东大会：
将于2016-06-16召开股东大会
会议内容 ▼▲
- 1.To elect the Board of Directors’ nominees, Dr. Remy Luthringer, Dr. Francesco De Rubertis, and Dr. Fouzia Laghrissi-Thode, to the Board of Directors to hold office until the 2019 Annual Meeting of Stockholders.
2.To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2016.
3.To conduct any other business properly brought before the meeting.
|